المؤلفون: Faller BA, Robu VG, Borghaei H, Faller, Bryan A, Robu, Valentin G, Borghaei, Hossein

المصدر: Clinical Lung Cancer; Nov2009, Vol. 10 Issue 6, p438-440, 3p

المؤلفون: Hochster HS; Rutgers Cancer Institute, New Brunswick, NJ, USA., Catalano P; ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Weitz M; ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA., Cohen D; Mt Sinai Hospital, New York, NY, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA., Faller BA; Missouri Baptist Medical Center/Heartland NCORP, St Louis, MO, USA., Kortmanky JS; Yale Cancer Center, New Haven, CT, USA., O'Hara MH; University of Pennsylvania, Philadelphia, PA, USA., Kricher SM; Northwestern University, Chicago, IL, USA., Lacy J; Yale Cancer Center, New Haven, CT, USA., Lenz HJ; Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Verma U; University of Texas, Southwestern Medical Center, Dallas TX, USA., Benson AB; Northwestern University, Chicago, IL, USA.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 May 22. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

المؤلفون: Hall WA; Froedtert and the Medical College of Wisconsin, Milwaukee, WI., Li J; The University of Pittsburgh, Pittsburgh, PA., You YN; University of Texas MD Anderson Cancer Center, Houston, TX., Gollub MJ; Memorial Sloan Kettering Cancer Center, New York, NY., Grajo JR; University of Florida, Gainesville, FL.; University of Florida Health Cancer Center, Gainesville, FL., Rosen M; Imaging and Radiation Oncology Core (IROC) Group, and the University of Pennsylvania, Philadelphia, PA., dePrisco G; Baylor Scott and White Health Baylor University Medical Center at Dallas, Dallas, TX., Yothers G; The University of Pittsburgh, Pittsburgh, PA., Dorth JA; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH., Rahma OE; Dana-Farber/Harvard Cancer Institute, Boston, MA., Russell MM; Department of Surgery, David Geffen School of Medicine at UCLA, and VA Greater Los Angeles Healthcare System, Los Angeles, CA., Gross HM; Dayton Clinical Oncology Program, Dayton, OH., Jacobs SA; NSABP Foundation, Pittsburgh, PA., Faller BA; Missouri Baptist Medical Center/Heartland NCORP, St Louis, MO., George S; Stephenson Cancer Center University of Oklahoma Health Sciences Center, Oklahoma City, OK., Al Baghdadi T; Trinity Health Ann Arbor Hospital, Michigan Cancer Research Consortium (NCORP), Ann Arbor, MI., Haddock MG; Mayo Clinic, Rochester, MN., Valicenti R; University of California Davis Comprehensive Cancer Center/UC Davis School of Med/UC Davis Health, Sacramento, CA., Hong TS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., George TJ; University of Florida, Gainesville, FL.; University of Florida Health Cancer Center, Gainesville, FL.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Oct 10; Vol. 41 (29), pp. 4643-4651. Date of Electronic Publication: 2023 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/diagnostic imaging , Adenocarcinoma*/drug therapy , Rectal Neoplasms*/diagnostic imaging , Rectal Neoplasms*/drug therapy, Female ; Humans ; Male ; Middle Aged ; Chemoradiotherapy/methods ; Magnetic Resonance Imaging/methods ; Magnetic Resonance Spectroscopy ; Neoadjuvant Therapy/methods ; Neoplasm Staging ; Treatment Outcome ; Prospective Studies

المؤلفون: Mohamed MR; James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York.; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York., Loh KP; James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York., Mohile SG; James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York., Sohn M; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York., Webb T; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Wells M; James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York., Yilmaz S; Department of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, New York., Tylock R; James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York., Culakova E; Department of Surgery, Supportive Care in Cancer, University of Rochester Medical Center, Rochester, New York., Magnuson A; James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York., Sun CL; City of Hope Comprehensive Cancer Center, Duarte, California., Bearden J; Spartanburg Regional Medical Center, Spartanburg, South Carolina., Hopkins JO; Southeast Clinical Oncology Research Consortium NCORP/Novant Health Cancer Institute, Winston-Salem, North Carolina., Faller BA; Missouri Baptist Medical Center, St. Louis, Missouri., Klepin HD; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina.

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Mar; Vol. 21 (3), pp. 273-280.e3.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy, Humans ; Female ; Aged ; Male ; Risk Factors ; Hospitalization ; Activities of Daily Living

المؤلفون: Bradbury AR; University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania., Lee JW; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Gaieski JB; University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania., Li S; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Gareen IF; ECOG-ACRIN Biostatistics Center, Brown University, Providence, Rhode Island., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Herman BA; ECOG-ACRIN Biostatistics Center, Brown University, Providence, Rhode Island., Domchek SM; University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania., DeMichele AM; University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania., Maxwell KN; University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania., Onitilo AA; Weston Center, Marshfield Clinic, Marshfield, Wisconsin., Virani S; Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin., Park S; Medical Oncology Hematology Consultants PA, Newark, Delaware., Faller BA; Missouri Baptist Medical Center, Saint Louis, Missouri., Grant SC; Wake Forest University Health Sciences, Winston-Salem, North Carolina., Ramaekers RC; CHI Health Saint Francis, Grand Island, Nebraska., Behrens RJ; Medical Oncology and Hematology Associates, Des Moines, Iowa., Nambudiri GS; Saint John's Hospital-Healtheast, Maplewood, Minnesota., Carlos RC; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan., Wagner LI; Wake Forest University Health Sciences, Winston-Salem, North Carolina.

المصدر: Cancer [Cancer] 2022 Apr 01; Vol. 128 (7), pp. 1381-1391. Date of Electronic Publication: 2021 Dec 10.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/genetics , Neoplasms*/therapy, Anxiety ; Female ; Humans ; Male ; Medical Oncology ; Precision Medicine ; Quality of Life

المؤلفون: Connolly RM; The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.; Cancer Research at UCC, College of Medicine and Health, University College Cork, Cork, Ireland., Zhao F; Dana-Farber Cancer Institute, Boston, MA., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Lee MJ; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Piekarz RL; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Smith KL; The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Brown-Glaberman UA; University of New Mexico Cancer Center, Albuquerque, NM., Winn JS; Fox Chase Cancer Center, Philadelphia, PA., Faller BA; Heartland NCORP, Missouri Baptist Medical Centre, Saint Louis, MO., Onitilo AA; Marshfield Clinic, Marshfield, WI., Burkard ME; University of Wisconsin Carbone Cancer Center, Madison, WI., Budd GT; Cleveland Clinic Foundation, Cleveland, OH., Levine EG; Roswell Park Cancer Institute, Buffalo, NY., Royce ME; New Mexico MU-NCORP, Albuquerque, NM., Kaufman PA; University of Vermont Cancer Center, Burlington, VT., Thomas A; Wake Forest University, Winston Salem, NC., Trepel JB; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Wolff AC; The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Sparano JA; Montefiore Medical Center, New York, NY.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 01; Vol. 39 (28), pp. 3171-3181. Date of Electronic Publication: 2021 Aug 06.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Androstadienes/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Aromatase Inhibitors/*administration & dosage , Benzamides/*administration & dosage , Breast Neoplasms/*drug therapy , Histone Deacetylase Inhibitors/*administration & dosage , Pyridines/*administration & dosage, Adenocarcinoma/chemistry ; Adenocarcinoma/mortality ; Adenocarcinoma/secondary ; Adult ; Aged ; Aged, 80 and over ; Androstadienes/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aromatase Inhibitors/adverse effects ; Benzamides/adverse effects ; Biomarkers, Tumor/analysis ; Breast Neoplasms/chemistry ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Breast Neoplasms, Male/chemistry ; Breast Neoplasms, Male/drug therapy ; Breast Neoplasms, Male/mortality ; Breast Neoplasms, Male/pathology ; Double-Blind Method ; Drug Administration Schedule ; Female ; Histone Deacetylase Inhibitors/adverse effects ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; Pyridines/adverse effects ; Receptor, ErbB-2/analysis ; Receptors, Estrogen/analysis ; Receptors, Progesterone/analysis ; South Africa ; Time Factors ; United States

المؤلفون: Rahma OE; NRG Oncology, Philadelphia, Pennsylvania.; Department of Medical Oncology, Dana-Farber Cancer Institute/Alliance, Boston, Massachusetts., Yothers G; NRG Oncology, Philadelphia, Pennsylvania.; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania., Hong TS; NRG Oncology, Philadelphia, Pennsylvania.; Department of Radiation Oncology, Massachusetts General Hospital, Boston., Russell MM; NRG Oncology, Philadelphia, Pennsylvania.; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.; David Geffen School of Medicine at UCLA, Los Angeles, California., You YN; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston., Parker W; NRG Oncology, Philadelphia, Pennsylvania.; Department of Medical Physics, McGill University Health Centre, Montréal, Quebec, Canada., Jacobs SA; NRG Oncology, Philadelphia, Pennsylvania., Colangelo LH; NRG Oncology, Philadelphia, Pennsylvania.; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania., Lucas PC; NRG Oncology, Philadelphia, Pennsylvania.; Department of Pathology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Gollub MJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Hall WA; NRG Oncology, Philadelphia, Pennsylvania.; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee., Kachnic LA; NRG Oncology, Philadelphia, Pennsylvania.; Department of Radiation Oncology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, New York.; SWOG Cancer Research Network, San Antonio, Texas., Vijayvergia N; NRG Oncology, Philadelphia, Pennsylvania.; Fox Chase Cancer Center, Philadelphia, Pennsylvania., O'Rourke MA; NRG Oncology, Philadelphia, Pennsylvania.; National Cancer Institute Community Oncology Research Program, Prisma Health Cancer Institute, Greenville, South Carolina., Faller BA; Missouri Baptist Medical Center, Heartland Cancer Research, National Cancer Institute Community Oncology Research Program, St Louis., Valicenti RK; Department of Radiation Oncology, UC Davis, Davis, California., Schefter TE; NRG Oncology, Philadelphia, Pennsylvania.; Department of Radiation Oncology, University of Colorado Cancer Center, Aurora., George S; Section of Hematology/Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City., Kainthla R; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Stella PJ; NRG Oncology, Philadelphia, Pennsylvania.; Department of Medical Oncology, St Joseph Mercy Hospital, Ann Arbor, Michigan., Sigurdson E; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Wolmark N; NRG Oncology, Philadelphia, Pennsylvania.; Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania., George TJ; NRG Oncology, Philadelphia, Pennsylvania.; Department of Medicine, University of Florida Health Cancer Center, Gainesville.

المصدر: JAMA oncology [JAMA Oncol] 2021 Aug 01; Vol. 7 (8), pp. 1225-1230.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy*/methods , Rectal Neoplasms*/drug therapy , Rectal Neoplasms*/radiotherapy, Anal Canal/pathology ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemoradiotherapy/methods ; Fluorouracil/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Organ Sparing Treatments

المؤلفون: Hensing TA; NorthShore University Health System Kellogg Cancer Center, University of Chicago, Evanston, Illinois., Wang X; Alliance Statistics and Data Center, Duke University, Durham, North Carolina., Stinchcombe TE; Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina., Gao J; Alliance Statistics and Data Center, Duke University, Durham, North Carolina., Knopp MV; Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Watson M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri., Dudek AZ; HealthPartners Cancer Care Center, St. Paul, Minnesota., Graziano SL; SUNY Upstate Medicine University, Syracuse, New York., Patel JD; Lurie Cancer Center Northwestern University, Chicago, Illinois., Faller BA; Missouri Baptist Medical Center, St. Louis, Missouri., Dragnev KH; Dartmouth-Hitchcock Norris Cotton Cancer Center, Lebanon, New Hampshire., Kozono D; Dana-Farber/Partners Cancer Care, Boston, Massachusetts., Vokes EE; Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

المصدر: JTO clinical and research reports [JTO Clin Res Rep] 2021 Jul 13; Vol. 2 (8), pp. 100208. Date of Electronic Publication: 2021 Jul 13 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

المؤلفون: Argiris A; Hygeia Hospital, Athens, Greece; University of Texas Health Science Center at San Antonio, San Antonio, TX. Electronic address: athanassios.argiris@gmail.com., Miao J; SWOG Statistics and Data Management Center, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA., Cristea MC; City of Hope, Duarte, CA., Chen AM; University of Kansas, Kansas City, KS [previous]/University of California Irvine, Irvine, CA., Sands JM; Lahey Hospital & Medical Center, Burlington, MA [previous]/Dana-Farber Cancer Institute, Boston, MA., Decker RH; Yale University, New Haven, CT., Gettinger SN; Yale University, New Haven, CT., Daly ME; University of California Davis, Sacramento, CA., Faller BA; Heartland NCORP/Missouri Baptist Medical Center, Saint Louis, MO., Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, IL., Yanagihara RH; Hawaii MU-NCORP/Straub Clinic & Hospital, Honolulu, HI., Garland LL; University of Arizona, Tucson, AZ., Byers LA; MD Anderson Cancer Center, Houston, TX., Wang D; Henry Ford Hospital, Detroit, MI., Koczywas M; City of Hope, Duarte, CA., Redman MW; SWOG Statistics and Data Management Center, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA., Kelly K; University of California Davis, Sacramento, CA., Gandara DR; University of California Davis, Sacramento, CA.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2021 Jul; Vol. 22 (4), pp. 313-323.e1. Date of Electronic Publication: 2021 Feb 19.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Carcinoma, Non-Small-Cell Lung/*therapy , Lung Neoplasms/*therapy, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Benzimidazoles/administration & dosage ; Carboplatin/administration & dosage ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemoradiotherapy/methods ; Dose-Response Relationship, Drug ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Paclitaxel/administration & dosage ; Progression-Free Survival ; Survival Rate

المؤلفون: Algazi AP; University of California, San Francisco, San Francisco, CA, USA. alain.algazi@ucsf.edu., Othus M; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Daud AI; University of California, San Francisco, San Francisco, CA, USA., Lo RS; University of California, Los Angeles, Los Angeles, CA, USA., Mehnert JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Truong TG; Kaiser Permanente Northern California, Vallejo, CA, USA., Conry R; University of Alabama, Birmingham, Birmingham, AL, USA., Kendra K; Ohio State University, Columbus, OH, USA., Doolittle GC; University of Kansas Hospital-Westwood Cancer Center, Westwood, KS, USA., Clark JI; Loyola University, Chicago, IL, USA., Messino MJ; Messino Cancer Centers-Asheville/ Southeast COR NCORP/Asheville, Asheville, NC, USA., Moore DF Jr; Cancer Center of Kansas/Wichita NCORP, Wichita, KS, USA., Lao C; University of Michigan, Ann Arbor, MI, USA., Faller BA; Missouri Baptist Medical Center Cancer Center/Heartland NCORP, St Louis, MO, USA., Govindarajan R; University of Arkansas, Little Rock, AR, USA., Harker-Murray A; Froedtert and the Medical College of Wisconsin, Milwaukee, WI, USA., Dreisbach L; Eisenhower Medical Center, Rancho Mirage, CA, USA., Moon J; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Grossmann KF; Huntsman Cancer Institute, Salt Lake City, UT, USA., Ribas A; University of California, Los Angeles, Los Angeles, CA, USA.

المصدر: Nature medicine [Nat Med] 2020 Oct; Vol. 26 (10), pp. 1564-1568. Date of Electronic Publication: 2020 Oct 05.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Imidazoles/*administration & dosage , Melanoma/*drug therapy , Oximes/*administration & dosage , Protein Kinase Inhibitors/*administration & dosage , Pyridones/*administration & dosage , Pyrimidinones/*administration & dosage , Skin Neoplasms/*drug therapy, Administration, Oral ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Administration Schedule ; Female ; Humans ; Imidazoles/adverse effects ; MAP Kinase Kinase Kinases/antagonists & inhibitors ; Male ; Melanoma/genetics ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Mutation, Missense ; Oximes/adverse effects ; Protein Kinase Inhibitors/adverse effects ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Proto-Oncogene Proteins B-raf/genetics ; Pyridones/adverse effects ; Pyrimidinones/adverse effects ; Skin Neoplasms/genetics ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Survival Analysis ; Treatment Outcome ; Young Adult